Ticker
YMABCompany Name
Y-MABS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 91.79M | 4 | $ 22.95M |
3/31/2025 | $ 90.45M | 4.77 | $ 18.96M |
12/31/2024 | $ 98.51M | 4.16 | $ 23.7M |
9/30/2024 | $ 99.06M | 3.92 | $ 25.29M |
6/30/2024 | $ 126.76M | 2.92 | $ 43.47M |
3/31/2024 | $ 108.27M | 6.15 | $ 17.61M |
12/31/2023 | $ 111.11M | 5.52 | $ 20.13M |
9/30/2023 | $ 114.86M | 5.27 | $ 21.81M |
6/30/2023 | $ 115.78M | 4.78 | $ 24.23M |
3/31/2023 | $ 124.01M | 4.78 | $ 25.92M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for Y-MABS THERAPEUTICS INC is calculated as follows: AssetsC [ $ 133.21M ] / LiabilitesC [ $ 19.78M ]
(=) Current Ratio [ 6.74 ]
Minimum
Jun 30, 2024
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.2K |
---|---|
min | 0 |
max | 6.79 |
average | 2.02 |
median | 1.62 |
std | 1.44 |